Results 31 to 40 of about 58,938 (145)

RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension

open access: yesBlood Pressure, 2023
Purpose Primary aldosteronism (PA), characterised by low-renin hypertension, confers a high cardiovascular risk and is the most common cause of secondary hypertension, with an increased prevalence in patients with treatment-resistant hypertension ...
Christian Beger   +6 more
doaj   +1 more source

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia

open access: yesFrontiers in Neuroscience, 2017
Renin-angiotensin-aldosterone system (RAAS) plays an important role in the regulation of blood pressure and brain function. Therefore, we studied the dynamic changes in the RAAS in the blood, cerebral cortex, and hippocampus and the effects of RAAS ...
Xinwu Huang   +6 more
doaj   +1 more source

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

open access: yesVascular Health and Risk Management, 2009
Eduardo Pimenta1, Suzanne Oparil21Endocrine Hypertension Research Center and Clinical Center of Research Excellence in Cardiovascular Disease and Metabolic Disorders, University of Queensland School of Medicine, Princess Alexandra Hospital, Brisbane, QLD,
Eduardo Pimenta, Suzanne Oparil
doaj   +2 more sources

Efficacy of Direct Renin Inhibitors in Slowing Down the Progression of Diabetic Kidney Disease: A Meta-Analysis. [PDF]

open access: yesCureus, 2022
Akbariromani H   +7 more
europepmc   +1 more source

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease

open access: yesActa Medica Indonesiana, 2020
Inhibition of the renin-angiotensin-aldosterone system (RAAS) is a key strategy in treating hypertension in cardiovascular and renal diseases. However, RAAS inhibitors (angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone ...
Yudi Her Oktaviono, Novia Kusumawardhani
doaj   +2 more sources

Regulation of the renin–angiotensin system in coronary atherosclerosis: A review of the literature

open access: yesVascular Health and Risk Management, 2008
Ramadan A Hammoud, Christopher S Vaccari, Sameer H Nagamia, Bobby V KhanEmory University School of Medicine, Division of Cardiology, Grady Memorial Hospital Vascular Research Laboratory, Atlanta, Georgia, USAAbstract: Activation of the renin&ndash ...
Ramadan A Hammoud   +3 more
doaj  

Discovery of Novel 2-Carbamoyl Morpholine Derivatives as Highly Potent and Orally Active Direct Renin Inhibitors. [PDF]

open access: yesACS Med Chem Lett, 2022
Iijima D   +17 more
europepmc   +1 more source

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction

open access: yesVascular Health and Risk Management, 2008
Paolo Verdecchia1, Fabio Angeli1, Giovanni Mazzotta1, Giorgio Gentile2, Gianpaolo Reboldi21Department of Cardiology, Clinical Research Unit ‘Preventive Cardiology’, Hospital ‘Santa Maria della Misericordia’, and Fondazione Umbra ...
Paolo Verdecchia   +4 more
doaj  

Hyponatremic hypertensive syndrome secondary to renal ischemia – Case report

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2018
Hyponatremic hypertensive syndrome (HHS) is characterized by hypertensive crisis, and hyponatremia secondary to unilateral renal damage with glomerular and tubular dysfunction. Elevated plasma levels of renin in most cases suggest that the stimulation of
Joana Cunha Oliveira   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy